CClinicalTrials.gg
Active, not recruitingNCT01647763Updated Aug 8, 2023

Hemorrhoidal Artery Ligation and Rectoanal Repair Versus Stapled Hemorrhoidopexy

An interventional study of Hemorrhoidal artery ligation with rectoanal repair and Stapled hemorrhoidopexy in Hemorrhoids, sponsored by Cantonal Hospital of St. Gallen. Active, not recruiting at 2 sites in Switzerland. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-08-08.

Sponsored by Cantonal Hospital of St. Gallen · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jul 2011, registered Jul 2012).
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Background:

Hemorrhoids of grade 3 and 4 can be treated either by conventional, rather invasive procedures, like Milligan-Morgan or Ferguson or by modern, less invasive procedures with less postoperative pain. Doppler guided hemorrhoidal artery ligation and stapled hemorrhoidopexy are examples for such modern procedures. Hemorrhoidal artery ligation causes less post operative pain than stapled hemorrhoidopexy, however the former has a higher recurrence rate. Combining hemorrhoidal artery ligation with rectoanal repair should reduce the recurrence rate without increasing the post operative pain.

Hypothesis and aim:

The study tries to prove the assumption that combined hemorrhoidal artery ligation and rectoanal repair cause less pain and have less post operative complications than stapled hemorrhoidopexy.

02

Conditions studied

  • Hemorrhoids

Browse trials for

Keywords

  • Hemorrhoids
03

In context

Hemorrhoids

221 studies on the registry are indexed under Hemorrhoids; 64 are open to participants now.

This study's planned enrollment of 84 is below the median of 97 across 169 interventional studies indexed under Hemorrhoids.

Browse Hemorrhoids studies →

Lead sponsor

Cantonal Hospital of St. Gallen is the lead sponsor of 79 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • hemorrhoids grade 3
  • no active anti-coagulation treatment
  • no hemorrhoidal recurrence
  • no previous surgery on rectum or anus
  • no previous local radiotherapy
  • no mental incapacities, good study compliance can be expected
  • no severe incontinence (Wexner score > 12)
  • no severe comorbidities
  • no inflammatory anal diseases (abscesses, fistulas)
  • informed consent

Exclusion criteria

Exclusion Criteria:

  • patient wish
  • inoperability with the assigned intervention, switching to other treatment method
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    HAL/RAR

    hemorrhoidal artery ligation with rectoanal repair

    Procedure: Hemorrhoidal artery ligation with rectoanal repair

  • Active comparator
    Stapled hemorrhoidopexy

    procedure for prolapse and hemorrhoids (PPH) Resection using a circular stapler

    Procedure: Stapled hemorrhoidopexy

Interventions

  • ProcedureHemorrhoidal artery ligation with rectoanal repair

    Hemorrhoidal arteries will be detected using an ultrasound Doppler probe. The arteries will be sutured with at least 4 Z-sutures. In the area with the 3 largest knots a purse string suture will be placed.

    Also known as: HAL (hemorrhoidal artery ligation), RAR (rectoanal repair)

  • ProcedureStapled hemorrhoidopexy

    A purse string suture will be placed just below the hemorrhoidal cushion. Fixing the suture around the shaft of a circular PPH 03 stapler (Ethicon Endo-Surgery). Hemorrhoids will be removed by firing the stapler. Sufficiency of the stapler line will be examined through a proctoscope. Eventual sources of bleeding will be sutured.

    Also known as: Longo procedure

06

What researchers measure

Primary outcomes

  1. Pain POD1

    Visual analogue scale (VAS). Additionally recording of the pain medication used.

    Time frame: between 6:00 am and 8:00 am the day after surgery

Secondary outcomes

  1. Pain after 8h

    Measuring post operative pain using the visual analogue scale (0 - 10). Additionally recording of the pain medication used.

    Time frame: 8 hours after surgery

  2. Pain 30d

    visual analogue scale

    Time frame: 30 days after surgery

  3. Pain 1y

    visual analogue scale

    Time frame: 1 year after surgery

  4. Pain 2y

    visual analogue scale

    Time frame: 2 years after surgery

  5. post operative surgical complications

    Number and severity according to the Dindo classification (Ann Surg 240:205)

    Time frame: within 30 post operative days

  6. duration of medical leave

    data will be obtained from primary care physician

    Time frame: up to 3 months after surgery

  7. Continence 30d

    Physician obtains data to calculate the Wexner Score (Dis Colon Rectum 36:77). Score will be compared with pre-operative score.

    Time frame: 30 days after surgery

  8. Continence 1y

    Wexner score

    Time frame: 1 year after surgery

  9. Continence 2y

    Wexner score Additionally anorectal manometry (results will be compared with pre-operative data).

    Time frame: 2 years after surgery

07

Study locations

2 sites
  • Kantonsspital Rorschach
    _Rorschach, 9400, Switzerland
  • Kantonsspital St. Gallen
    St. Gallen, 9007, Switzerland
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01647763
Lead sponsor
Cantonal Hospital of St. Gallen
Responsible party
Lukas Marti (Leitender Arzt (attending surgeon), Cantonal Hospital of St. Gallen) — Principal investigator
First posted
Jul 24, 2012
Start date
Jul 2011
Primary completion
Dec 2022
Completion
Dec 2024 (estimated)
Last update
Aug 8, 2023

Study contacts

Lukas Marti, MD
principal investigator · Cantonal Hospital St. Gallen, Department of Surgery

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion